Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent vs Continuous Leuprorelin and Flutamide in Metastatic Prostate Cancer
NCT00817739Phase 2Completed
- Sponsor
- Takeda
- Start
- Dec 1996
- Primary completion
- Sep 2005
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 2 trial of leuprolide in Metastatic Prostate Cancer (mPC), sponsored by Takeda. Started Dec 1996; status: completed.
02
Drugs
leuprolide
03
Conditions
Metastatic Prostate Cancer (mPC)
Beyond the preview
Go deeper on NCT00817739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00817739.